02Jul/13

BioInvent extends collaboration for the discovery and development of … – PipelineReview.com (press release)

BioInvent extends collaboration for the discovery and development of
PipelineReview.com (press release)
LUND, Sweden I July 2, 2013 I BioInvent International AB (OMXS: BINV) today announces that it has signed an extension to its 2009 license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies from BioInvent’s 

and more »

02Jul/13

NICE issues second draft guidance on the use of Pixuvri as monotherapy to … – pharmabiz.com

NICE issues second draft guidance on the use of Pixuvri as monotherapy to
pharmabiz.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have